Funding Details
- Awarder
- Inbox
- Date Award
- February 25, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Company Description
- Auron Therapeutics is a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease.
- Market
- Oncology and inflammatory disease
- Location
-
NEWTON,
MA,
USA
- Coinvestors
- DCVC Bio, Apollo Health Ventures, Arkin Bio Ventures, BrightEdge, Casdin Capital, Franklin Berger, Mubadala Capital, Polaris Partners, Qiming Venture Partners USA
Links